Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
AMN Healthcare, a medical staffing firm based in Texas, has acquired a virtual care company that specializes in home health and outpatient care for $42 million.
Natural language processing of social media posts is useful for identifying depression, anxiety and suicidal thinking, but models trained on population data cannot discern long-term patterns in any one person’s state of mind.
AI is poised to help settle an argument that’s been roiling academic psychiatry for more than a century: Are bipolar disorder and schizophrenia two distinct diagnoses—or points along a single continuum?
Researchers at Duke University are working on a vaccine that has the potential to stop future pandemics by protecting against a variety of coronavirus infections that can jump from animals to humans.
A novel AI-based model for clinical decision support has bested established machine-learning models at predicting how patients with type-2 diabetes mellitus will respond to various categories of therapeutic drugs.
Researchers have developed an AI system that can differentiate primary tumors from metastatic lookalikes on routine histology slides while also helping pinpoint the sites from which the cancer sprung.
